Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001183 · ClinicalTrials.gov registry record
Evaluation of the Causes and Disease Processes of Chronic Lung Disease
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 6,564
- Enrollment target
NCT00001183: Completed study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00001183 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 6,564 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001183 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 6,564 participants
- Enrollment target
Study Summary
Chronic lung diseases are disorders associated with abnormalities in any of the structures involved in the process of breathing and bringing oxygen into the lungs and blood. This includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the tissue covering the lungs (pleura). The purpose of this research study is to evaluate patients referred to the Cardiovascular and Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI) in order to; 1. Develop a better understanding of the causes and disease processes involved in disorders of the lungs 2. Identify patients eligible to participate in other P-CCMB research studies
Primary Outcome
Evaluate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,564 participants |
| Start Date | 1984-11-18 |
| Est. Completion | 2019-12-16 |
What the finished NCT00001183 record still lists
NCT00001183 is an observational study that tracks outcomes without assigning an intervention. Its 6,564 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001183 about?
NCT00001183 is a clinical study titled "Evaluation of the Causes and Disease Processes of Chronic Lung Disease". Chronic lung diseases are disorders associated with abnormalities in any of the structures involved in the process of breathing and bringing oxygen into the lungs and blood. This includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the tissue covering the lungs (p...
What is the current status of trial NCT00001183?
This trial is currently completed. The enrollment target is 6,564 participants. The study started on 1984-11-18. Estimated completion is 2019-12-16.
Who is sponsoring clinical trial NCT00001183?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
- NCT05515224 · 6,600 participants · NA
5-Cog 2.0: A Pragmatic Clinical Trial
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI